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Editor
John Curtis

Thank you for articles
on children and microbes
What a wonderful recent edition of Yale Medicine [Spring
2015]! Two articles particularly
affected my pediatric mindset
and got me thinking (a little
harder to do at my age):
“How children rebound from
their worst nightmares” and
“A bug’s journey.”
I have been concerned about
so many children in our prosperous country receiving little “parenting” or supervision. Surrogate
“caregivers,” in my mind, just
can’t cut it. Without instruction
or modeling, a child doesn’t just
automatically metamorphose
into a good kid that has no need
for behavior-modifying drugs.
Contrast the prosperous with the
opposite—occupants of a Syrian
refugee camp.
I witnessed penicillin as
both a miraculous germ killer
and as the ineffective antibiotic it became for strains of
Staphylococcus aureus: first
as a Navy hospital corpsman
treating the “sins” of returning
Marines with aqueous penicillin delivered by a syringe with
a huge needle on one end; and

later, witnessing the discovery that newborns with Staph
pneumonia were dying in spite
of penicillin’s being administered. As time progressed, I
realized that I needed more
knowledge of how our immune
systems work and how
pathogens could outsmart
us. I attended seminars on
immunology that, I have to
admit, were over my head.

If only I had read this article
40 (maybe 50) years ago. I loved
the teaching of the difference
between RNA viruses and DNA
bacteria in the context of their
mutation “mistakes” or other
means of change.
A very interesting edition.
Thank you.
Ralph K. Campbell, M.D. ’50
Polson, Montana
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dialogue

		 “Almost every disease
is influenced in some
manner by inheritance”
both
genetic and environmental, determine who we
are? We asked Yale faculty and students to reflect
on this question in many ways for this issue of
Yale Medicine. Dean Robert J. Alpern, M.D.,
discussed what he has inherited from those who
served as dean before him, and the importance
of evolution and heredity to science.
H OW D O O U R I N H E R I T E D T R A I T S ,

This issue of Yale Medicine explores the concept of inheritance from many angles. What makes this subject so rich?
Almost every disease is influenced in some manner by inheritance, including not only genetics and
epigenetics, but that which we “inherit” from the
environment our parents establish for us. While many
diseases involve random environmental factors, our
response to those elements is determined by our
genetic background.
As a scientist, what interests you most about inheritance?
Evolution has a profound effect on everything we are,
including the diseases that affect us and our response
to those diseases. When humans were content to live
until their children became independent, evolution
was our friend. Now we live long past the age required
for survival of our species, and we are on our own with
no support from evolution.

JENNIFER STOCKWELL SUNPRINT

You are the 16th dean of the School of Medicine. What have
you inherited from your predecessors? I have inherited
many great things from previous deans, among them
the Yale system of medical education, and a preeminent medical school.
What do you imagine our legacy—that of YSM of the early
21st century—will be? I hope that our legacy will be that
we have advanced excellence in education and research,
while introducing a renewed commitment to an outstanding clinical practice.
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Alum’s appointment
as surgeon general a “home run”
I N M A RC H 2 0 01,

Esther K. Choo, M.D. ’01, then a medical

student, was bouncing around in a jeep on bumpy desert
roads in Gujarat, India, feeling sick from the heat and the
antiretroviral medications she was taking. At her side
was fellow medical student Vivek H. Murthy, M.D. ’03,
M.B.A. ’03. They were part of a team from Yale that was
providing relief after an earthquake. On this mission they
also addressed medical needs unrelated to the immediate crisis. While drawing blood samples at a screening
for diabetes and cardiac disease, Choo pricked her finger
with a used needle. She and Murthy were scouring the
countryside for the woman whose blood she had been
exposed to, so they could test her for HIV. They found the
woman, and she tested negative. “Vivek volunteered to go
with me to hold my hand and keep me from freaking out,”
Choo said. “He is just that kind of person.”

4

yalemedicine.yale.edu

C H R I S S M I T H / H E A LT H A N D H U M A N S E R V I C E S

While in Gujarat, said Choo,
now an emergency physician at
Brown University, one of their
faculty preceptors told the students that they were all bright
but that Murthy would make his
mark in a very big way. “None of
us took offense, because it was
so obvious,” Choo said. “He was
the moral center of the group.
He was unflappable and calm,
no matter what was going on.”
In January the U.S. Senate
confirmed Murthy’s appointment as the nation’s 19th surgeon general. His nomination
by President Barack Obama
had been on hold for more than
a year due to opposition from
Republicans and the National
Rifle Association. His offense?
A 2012 tweet on gun violence:
“Tired of politicians playing politics w/guns, putting lives at risk
b/c they’re scared of NRA. Guns
are a health care issue.” He was
also criticized for his youth and
relative inexperience—he is 38.
Yet support came from more than
100 national health organizations,
including the American College
of Physicians, the American
Public Health Association, the
American Cancer Society, and
the Association of American
Medical Colleges, as well as from
two former Surgeons General.
Anyone at the med school
between the fall of 1998, when
Murthy matriculated, and
2003, when he graduated, probably has a story about him. As
one student of that time put
it, “Everyone knows Vivek.” He
arrived at Yale with a record of

accomplishment dating back to
his high school days in Florida,
when he got his classmates to
mentor middle school students.
As a Harvard undergrad, he
launched a peer education program that trained American
college students to teach students in India about HIV/AIDS.
He also started a community
health partnership in rural India
that trained young women to
be health educators and basic
health care providers. During
his first year as a med student,
he was profiled in The Chronicle
of Philanthropy for his efforts.

When he spoke, classmates
said, others paid attention. “He
would often listen quietly to
a discussion of a controversial
topic,” former class president
Andrew D. Norden, M.D. ’02,
M.P.H., now a neurologist in
Boston, wrote in an email. “He
would wait until the opposing
viewpoints were on the table
and finally make a critical comment that recognized an understanding of each position, and
suggest a thoughtful path to
resolution. He frequently got the
last word in because once he had
spoken, everyone could be seen
nodding in agreement.”
Auguste H. Fortin VI, M.D.,
M.P.H., associate professor of
medicine, recalled Murthy
returning from a visit to the

Vivek Murthy became the
fi st graduate of the School
of Medicine and the first
American of Asian descent
to be confirmed as the
U.S. Surgeon General.
Vice President Joe Biden
swore him in during a
ceremony on April 22.
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Watch the first TV
interview with the new
surgeon general on
cbsnews.com. Vivek
Murthy is the first
Yale alumnus to serve
in the post and one
of the youngest in
recent memory.
And for more on
Murthy’s swearingin ceremony, visit
yalemedicine.yale.edu/
murthy.
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University of California, San
Francisco (UCSF), where he’d sat
in on “The Healer’s Art,” a class
that explores the human dimensions of medicine, taught by
Rachel Naomi Remen, M.D.
“He came back very excited
and enthusiastic,” Fortin said.
“He said we have to do this at
Yale. He recognized that there
was a need for students to talk
about meaning in medicine.”
Murthy worked with Fortin
and Margaret J. Bia, M.D.,
FW ’78, professor of medicine,
to establish The Healer’s Art, a
small-group elective now in
its 15th year. Over four weeks,
students discuss such topics
as what it means to be a healer,
what it’s like to lose a patient,
and how to avoid burnout. Yale
was the first medical school
after UCSF to offer the course,
and now more than 70 medical
schools have followed suit. “I
think we have Vivek to thank
for that,” Fortin said.
After graduating from Yale,
Murthy founded TrialNetworks,
social networking platforms
for clinical trials that enhance
communication, collaboration,
and overall efficiency. During
the 2008 presidential campaign
Murthy and colleagues founded
Doctors for Obama. After the
election, the group became
Doctors for America, a grassroots organization of doctors
and medical students working to
improve access to health care. In
2011, President Obama appointed
Murthy to the national Advisory
Group on Prevention, Health

Defending the “good”
bacteria

Promotion, and Integrative and
Public Health. The following
year Murthy served as co-chair
of the health care advisory
committee for Obama’s reelection campaign.
During the more than yearlong wait for a vote on his
nomination, Murthy remained
optimistic. And when he returned to Yale as the medical school’s Commencement
speaker last year, students wore
decals on their gowns that read
“Yale Stands with Vivek.”
“Those of us closest to Vivek
during this time maintained our
optimism,” said one of his mentors, Howard P. Forman, M.D.,
professor of diagnostic radiology,
of economics, of management,
and of public health (health
policy), and director of the
M.D./M.B.A. Program. “We were
very certain there was a window of opportunity, and that
his many supporters, including
those in the White House, would
use that to the best advantage.
Despite the rhetoric before the
confirmation, I think that he is
a thoughtful, nonpartisan, very
deliberate physician who sees
the role of the Surgeon General
as an amazing opportunity to
be the nation’s leading spokesperson on health and public
health issues.”
“Vivek does everything so
selflessly and is one of the brightest, off-the-charts-smartest
people that I know,” said Choo.
“We hit a home run getting Vivek
into this role.”
—John Curtis

When faced with dangerous
bacteria like Salmonella, the gut
releases inflammatory molecules
to destroy the invaders. That
immune response is so nonspecific that in theory at least, it
should kill indiscriminately. Yet
the many healthful and even
beneficial bacteria that reside in
the gut seem unaffected by the
friendly fire. So-called commensal strains persist for years
through one inflammatory event
after another.
A group of researchers led
by Andrew Goodman, Ph.D.,
assistant professor of microbial
pathogenesis and a member of
the Microbial Sciences Institute
at West Campus, recently figured out why: many of the most
prominent and stable commensals wield a protein that fends
off the antimicrobial peptides
(AMPs) that the host uses to
attack the invaders. The team
reported in Science in January
that the protein LpxF serves a
little like an umbrella, allowing
bacteria to readily shed AMPs
at concentrations thousands of
times higher than those that
kill pathogens.
The discovery, said Goodman,
opens the door for researchers to
learn “not only how the host tolerates the microbiome—which is
well studied—but how the microbiome tolerates the host.”
LpxF works by removing a
negatively charged phosphate
group from the bacterial surface. That keeps the positively

»

B R I A N F I T Z G E R A L D I L L U S T R AT I O N

A caring surgeon,
struck down in an act
of senseless rage

charged AMPs—the gut’s
defenders—from binding to bacteria and destroying them.
The LpxF discovery and
its satisfying simplicity may
mean that the field—which has
focused mostly on describing its
species diversity—is now poised
to move into an exploration of
how the ecosystem functions.
Understanding that ecosystem
is a sine qua non for pursuing
potential therapeutic targets.
Goodman, who is trained
in both microbial genetics and
ecology, had previously assumed
that the host-pathogen commensal relationship would be
byzantine and difficult to study.
Now he is optimistic.
“It’s a glimmer of hope that
it’s not going to be so irreducibly complex that we won’t be
able to make any headway,”
Goodman said, “[and] that

there are dedicated mechanisms that we can identify and
potentially target.”
LpxF is likely to be one of
many resiliency factors waiting to be discovered in the gut,
some of which may point to
new drugs. This line of study is
especially important because
faulty or damaged resiliency
systems might explain certain
forms of disease. Studies of the
gut microbiome have typically
focused on the bacterial communities of healthy people. But
understanding how these communities behave in sick people is
crucially important, too. That’s
Goodman’s next goal.
—Jenny Blair

Michael J. Davidson, M.D. ’96,
was a heart surgeon, one of a
fraternity well-known for its
bravado, but family, friends, and
colleagues remember him as
one of the gentlest souls ever to
wield a scalpel.
He practiced in an area of
medicine where a clear divide
separates cardiac surgeons from
cardiologists, but he trained
as both. He spent unhurried
hours with patients and their
families, answering their questions, calming their fears, and
earning their gratitude—until,
one morning in January, the son
of a patient shot Davidson outside an exam room at Brigham
and Women’s Hospital (BWH)
in Boston. Davidson died hours
later, despite the best efforts of
his colleagues.
His assailant, a 55-yearold man from the Boston area,
was subsequently found dead,
apparently from a self-inflicted
gunshot wound. Police said the
shooter blamed Davidson for his
mother’s death in November.
“Surgeons are not known
for their bedside manner, but
Michael had it in spades,” said
Terri Halperin, M.D., Davidson’s
wife. “That is why the fact
that a patient’s family member would take Michael away
from us makes it all the more
devastating.”
At his funeral in Wellesley,
Mass., Davidson was recalled as
a problem solver who could take
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How two second-years
launched a course in
health justice
Yale med students join
in national protest
Storytelling at the heart
of the medical enterprise
Full stories and event
photo galleries, as well
as other online-only
content, can be found
on our home page at
yalemedicine.yale.edu.
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apart and fix a refrigerator or
install a hardwood floor. He did
his own electrical work. Before
coming to Yale, he earned his
bachelor’s degree at Princeton,
where he was a competitive
fencer and president of the soaring club. In college he taught
himself to play the guitar and
played in a rock band. He decided
to run the Boston Marathon on
his 40th birthday and finished
with a respectable time.
“We would have everything
from live lobster races on the
floor of our apartment, to the
annual tradition of our Passover
turkey, to 10-course, free-form
Asian explorations with five
woks going,” recalled Joshua M.
Rosenow, M.D. ’96, his medical
school roommate for three years.
In interviews, others who
knew him struggled to understand how Davidson had become
the object of rage. “None of it
makes sense,” said Jamie M.
McCabe, M.D. ’04, who trained
under Davidson at BWH for
two years. “He was a calm and
thoughtful guy, an extremely
hard worker, and very dedicated.
He was just a genuinely sweet
person.” Davidson’s thesis advisor, Robert J. Touloukian, M.D.,
remembers him as “very softspoken, intelligent, inquisitive.”
“There are people in surgery
who are fundamentally aggressive. Mike was fundamentally
a very gentle and caring person,” said Samantha Hendren,
M.D. ’96, M.P.H., a colorectal
surgeon at the University of
Michigan. “That makes it all

Classmates Michael Davidson, right, and
Josuha Rosenow, together on Match Day in
March 1996. Rosenow recalled the moment
upon seeing the photo in February 2015 for
the first time: “Michael had just received his
match results, and I was holding up one finger
because he got his first choice.”

the more unjust that his life
ended violently.”
Davidson was director of
endovascular cardiac surgery at
BWH and a member of the faculty at Harvard Medical School.
During his residency, he moved
from Duke to Boston to be with
Halperin, and he completed fellowships in endovascular surgery and cardiac catheterization
and in cardiac surgery.
Frederick C. Welt, M.D. ’92,
met Davidson at BWH. With
their colleague Andrew C.
Eisenhauer, M.D., they led the
team that implemented transcatheter valve replacement at
BWH. The minimally invasive
technique had been pioneered
in France in 2002 and, according to Welt, “involved cooperation between surgeons and
cardiologists—not always an
easy thing to do.”

“Mike was incredibly talented.
He was already obviously a welltrained surgeon, yet he took a
year out of his life to cross-train
in the world of interventional
cardiology,” Welt, now at the
University of Utah, wrote in
an email. “It was an effort that
took time away from the OR,
and he paid a financial price for
that in terms of the operative
time that he gave up. But he was
completely committed, and … he
developed into somebody who
was really as good with those
skills as anyone at the table.”
Davidson recognized that
the dividing lines between
disciplines were “weird and
arbitrary,” added McCabe, his
former trainee, “and that the
best way forward was building
those really tight bonds between
interventional cardiology and
cardiothoracic surgery to provide a kind of whole new spectrum of care.”
According to Michael
J. Zinner, M.D., chair of the
Department of Surgery at BWH,
Davidson “was one of only two
or three cardiac-trained surgeons in the country who were
doing this kind of work and
would go on … to make incredible innovations in this area.”
Davidson’s former chief,
Ralph M. Bolman III, M.D.,
agreed. “Mike had a vision for
a new heart doctor, one who is
really going to be, and is, the
doctor of the future,” Bolman
said. “He was one of the very
first to act on this vision.”
—Michael Fitzsousa

a collection of recent
scientific findings
THE “NOISE”
IN HUMAN CELLS
A Yale-led team of scientists has
developed a method for mapping cellular “noise,” variations in how human
cells react to chemical signals. Their
findings, published in Proceedings
of the National Academy of Sciences,
could help tailor drug delivery and
advance semiconductor chip design.
The method, devised by systems biologist and biomedical engineer Andre
Levchenko, Eng.Sc.D., is based on
each cell’s unique reactions to chemical signals—some cells react strongly,
while other cells may not react at all.
“Knowing how variable the activity is
allows us to better target the spectra of activities in those networks,”
said Levchenko, the John C. Malone
Professor of Biomedical Engineering
and inaugural director of the Systems
Biology Institute at West Campus.

		 THE BIGGER YOUR
PARIETAL CORTEX,
THE BIGGER THE
		 RISK YOU’LL TAKE

A R T: T H I S PA G E , I S T O C K P H O T O . C O M ; O P P O S I T E PA G E , F R A N K P O O L E P H O T O

PSYCHOLOGIST
DECODES “TEARS OF JOY”

A Yale team led by Ifat
Levy, Ph.D., assistant professor in
comparative medicine and neurobiology, reported in the Journal of
Neuroscience in September that
people who have larger volume in a
particular part of the parietal cortex
are willing to take more risks than
those with less volume. “Based on
our findings, we could, in principle,
use millions of existing medical
brain scans to assess risk attitudes
in populations,” said Levy. “It could
also help us explain diff rences
in risk attitudes based in part on
structural brain differences.”

Why do people emit a nervous laugh
in uncomfortable situations? And why
are parents who cry at their child’s
graduation also more likely to pinch
a cute baby’s cheeks? Yale psychologist Oriana R. Aragón, Ph.D., ’14, now
understands why people cry when
they are happy. “People may be restoring emotional equilibrium with these
expressions,” said Aragon, lead author
of work published in Psychological
Science. “They seem to take place
when people are overwhelmed with
strong positive emotions, and people
who do this seem to recover better
from those strong emotions.”

SURGEONS AND ENGINEERS
JOIN FORCES ON 3-D ORGANS
Yale surgeons and biomedical engineers are working with a biology
company to develop 3-D printed
tissues for transplant research. With
demand for transplanted organs
and tissues increasing and supplies
shrinking, 3-D organs would shorten
the amount of time patients would
have to wait. Since the transplanted
cells would come from the patient’s

own body, the technology would
eliminate the need for immunosuppressive drugs. “This field may provide
a unique and new opportunity where
we can print 3-D organs that can
supplement or replace the shortage
of organs out there worldwide,” said
John P. Geibel, D.Sc., M.D., vice chair
and director of surgical research and
professor of surgery (gastrointestinal)

and of cellular and molecular physiology at the School of Medicine. In
the first phase of the collaboration
with Organovo Holdings Inc., Yale
researchers would develop 3-D arteries and veins that would replace
plastic stents as connective tissue
in transplants. The second phase of
the project would involve printing an
entire organ—the small intestine.
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From one
generation to the next
How ideas, traditions, physical traits, and even
disease become the legacies we inherit.
IN T HE L AT E 1970 s, an archaeologist exploring the Colombian Andes for

tombs and relics of past civilizations met an elderly farmer who told him
of a field where, as a child, he had been forbidden to play. The field was
dangerous, his mother told him, because of the two-headed monster that
lived there. The archaeologist and his team excavated the site—buried in
the field, they found the full-size statue of a man with two heads.
Who made the statue and how it came to be buried there remained
mysteries. Yet somehow, as in a game of Telephone, knowledge of the
statue had passed down through the generations. With each telling, the
story changed. DNA similarly passes from generation to generation, but it
doesn’t always come out right. Ideas move through time, and they change
with the times. We inherit many things from our ancestors, be they blue
eyes and brown hair, notions of right and wrong, or just habits and ways
of being. In this issue of Yale Medicine, we look at the ways in which
these inheritances emerge intact—or sometimes not.
This issue’s feature articles explore what DNA reveals about human history, how med school traditions endure or fall by the wayside, and how
one family copes with an inherited disease.
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Six degrees
of Paul Beeson
T H E I RO N T E R N S , as they were known, began their internships in medicine

under Paul Beeson, M.D. (fifth from left, front row) in the 1960s. Jack Levin,
their chief resident, coined the name at a softball game marking the end
of their internship year. The name was an abbreviation of intern and their
moniker of “iron men” for their stamina on the wards. Of the 14 physicians in
this group, nine went on to become full professors; four held endowed chairs;
five became department chairs; one became a medical school dean; and two
became division chiefs. Collectively, they published more than a thousand
articles. The legacy of Paul Beeson, dubbed the “Beeson mystique,” has been
handed down through them to later generations of physicians. In June 1965,
the Iron Terns posed on the steps of the Sterling Hall of Medicine with Beeson
and the assistant residents in internal medicine.
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5 Michael Viola, M.D.,

3 James J. Fischer,

M.D., Ph.D., HS
’65, was chair
of therapeutic
radiology at Yale
for 30 years, and
played a major
role in improving
radiation therapy.

1 Stephen Ross,

M.D., HS ’69, FW
’73, was in private
practice in Maine.

HS ’66, delivers
health care in
the developing
world as the chief
medical officer
of Medicine for
Peace, which
he and his wife
founded along
with the MFP
Center for Torture
Victims in Washington, D.C. In his
earlier career he
was a professor of
medicine at the
University of Connecticut and SUNY
Stony Brook.

6 Ira Silverstein,

M.D., HS ’65, was
in private practice
in psychiatry in
New York City and
Laguna Beach,
Calif. He was also
a member of the
part-time faculties of the schools
of medicine of Columbia University
and the University of California,
Irvine.

2 Dave Dear, M.D.,

HS ’66, a cardiologist, lowered the
mortality rate
in heart surgery
from 50 percent
to 1 percent in
just one year
in a hospital in
Mississippi.

4 Larry Knight, M.D.,

HS ’67, FW ’68,
was both chief
of staff nd chair
at the Elkhart
Clinic in Indiana,
an early multispecialty clinic.

Paul Beeson, M.D., chaired internal medicine
from 1952 to 1965 and taught the importance of
treating patients as human beings. He mentored
scores of young doctors who went on to make
their mark in medicine.
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7 Lewis Landsberg,

M.D. ’64, HS ’70,
was dean of the
medical school
at Northwestern
University. As a
researcher, he
made major
contributions to
the understanding
of hypertension
and the role of
the sympathetic
nervous system.

10 Jack Levin, M.D.

8 Richard Lee, M.D.

’64, HS ’70, FW ’71,
was a professor
of medicine, obstetrics, pediatrics,
anthropology, and
social and preventive medicine.
He wrote 44 essays for the
American Journal
of Medicine;
81 essays and
commentaries;
and a book on his
medical travels.

’57, HS ’65, though
not an iron tern,
served as their
chief resident. He
was a professor
of medicine at
Johns Hopkins and
professor of laboratory medicine
and medicine at
the University of
California, San
Francisco. At the
Marine Biological Laboratory in
Woods Hole, Mass.,
with his colleague
Frederik Bang,
M.D., he developed the Limulus
amebocyte lysate
test, which is used
to detect bacterial endotoxins in
parenteral drugs,
intravenous fluids,
and medical
devices.

11 Hugh Tilson, M.D.,

Dr.P.H., HS ’65, an
epidemiologist
and outcomes
researcher, was
director of product surveillance
at Burroughs
Wellcome, and
of epidemiology,
surveillance, and
policy research at
GlaxoWellcome.
Most recently,
he has served
as a county
health officer in
Bath, Maine, and
adjunct professor
at the UNC School
of Public Health in
Chapel Hill.

13 John Burke, M.D.,

HS ’67, was one
of the first to use
modern computer
technology for
surveillance of
patients with infectious diseases.
He trained 70 fellows in infectious
diseases at the
University of Utah.

15 Harold Federman,

M.D., HS ’65, personally delivered
hospice and
palliative care to
hundreds of patients while establishing a hospice
organization in
Cooperstown, N.Y.

14 Thomas Spack-
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9 John N. Forrest Jr.,

M.D., HS ’70, FW
’71, has directed
student research
at Yale for 29
years, and has
seen more than
2,500 medical
students pass
through the
program.

12 Peter Gross, M.D.,

HS ’66, FW ’71,
spent much of
his career in
epidemiological
surveillance and
quality improvement, and was
chair of medicine
at Hackensack
University Hospital in New Jersey.

man, M.D., HS ’69,
moved into the
business world
after a career at
the University of
Connecticut. He
became the chair,
CEO, president, or
managing director
of companies in
medical imaging
and medical care.
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Written
in blood
Ken and Judy Kidd’s bank of
2,600 cell lines contains the
secrets of our evolution and
perhaps our future health—
why would they destroy it?
By Kate Wheeling | Robert A. Lisak Photos
In 1959, in a burgeoning riverside market town in what
was then the Belgian Congo, a Bantu man fell ill.
An unknown virus was replicating furiously in the
white blood cells circulating in his veins. A sample
of his blood, taken for a study of the genetic diseases
of red blood cells, was frozen and forgotten for nearly
three decades. It contained traces of the mysterious
virus that would take some 20 million lives worldwide
by the year 2000: the human immunodeficiency virus
(HIV), a retrovirus that thrives within the very cells
meant to fight off invaders.
Blood is an ephemeral substance. Red blood cells,
which make up nearly half of the blood’s volume, have
a life span of just 120 days, give or take a week. Four
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months from now, every one of the 25 trillion or so biconcave blood cells sailing through the body’s veins
and arteries at this moment will have been consumed
by macrophages and replaced by brand-new oxygentoting cells. Outside the body, blood cells break down
in 24 hours or less.
Frozen blood, on the other hand, is a liminal substance—neither alive nor dead. The Bantu man’s frozen
blood became a snapshot of the past, and as medical technology and tests advanced, a resource for the
future. Eventually, the Bantu man’s blood would help
scientists trace the origins of one of humanity’s deadliest epidemics.
Not only can frozen blood be used to track the
spread and evolution of the diseases that plague
humans, but it can also transcend disciplines, providing valuable insights to geneticists, anthropologists,
and immunologists alike. Within those blood cells are
traces of humanity’s evolutionary history.
For more than four decades, blood has been the main
focus of the work of Kenneth K. Kidd, Ph.D. A professor
of genetics, of ecology and evolutionary biology, and of
psychiatry at Yale, Kidd got his start in genetics at the
University of Wisconsin, where he studied blood group
typing to identify and register purebred cows.
In the 1980s, when population geneticists acquired
the tools to look directly at DNA, Kidd and his wife,
Judith R. Kidd, Ph.D. ’93, switched to human subjects.
“We gradually moved more and more into population
studies, just because they’re fascinating,” said Ken. The
Kidds became interested in the genetic variations that
occur between geographically distinct populations.
“There is just a terrific amount you can learn from
the study of human populations,” said Judy, a retired
research scientist in the Department of Genetics
who earned her Ph.D. in anthropology. “When Ken
was studying cattle genetics as a graduate student, I
thought, ‘Oh, that’s interesting.’ But once he moved to
humans, I thought, ‘Oh, that’s interesting!’ ”
Their work on genetic variation has helped to piece
together the human genetic map. The Kidds have
scoured the genome for genes involved in complex
neuropsychiatric disorders, narrowing down genes
that play a role in Tourette syndrome, schizophrenia,
and alcoholism. They’ve also used DNA polymorphisms
to trace human origins. Their research has shown
that sub-Saharan African populations tend to have
more variation in certain genes than other populations throughout the world, which could mean that
the genes have had more time to accumulate mutations

Kenneth and Judith Kidd have
collected blood samples from
around the world. Those samples
have yielded clues to the history
of humankind.
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and diversify in those African groups. This work bolsters the theory that modern humans spilled out of
Africa to populate the rest of the world.
The Kidds share all the data on genetic variation they
collect in a publicly accessible bioinformatics database
that they affectionately call ALFRED, short for the Allele
Frequency Database. But the physical cell lines themselves are locked inside steel-colored freezers in their
New Haven lab. As the Kidds wind down their careers,
what will happen to their collection is an open question.

a “c o l d c h a i n” t o mo v e bl o o d

Cold storage is not new; insulated iceboxes have been
around for at least 200 years. Your grandmother probably had a mechanical refrigerator to keep her perishables cool before one was ever used to chill blood.

Radin, an assistant professor in the history of medicine
whose work examines the ways in which technologies of
cold storage have transformed the practice of biomedicine and public health. This chain was not without kinks.
In 1968, a World Health Organization (WHO) report
advised researchers to scratch serial numbers directly
onto the glass vials after several shipments of specimens
were unidentifiable upon arrival at labs—presumably, the
labels had washed off in melted ice.
The WHO, famous for its work on infectious diseases, was quick to recognize the potential benefits of
cold storage. The agency saw the collection of serum,
the liquid component of blood, as a way to expand
the study of current diseases in remote parts of the
globe and to prepare for the diseases of the future.
As new diseases—and tests for their detection—
emerged, researchers could thaw frozen serum samples and study them in light of such medical advances.
The agency established four serum banks, repositories of frozen samples, to serve as a biomedical
resource. The only one in the Western Hemisphere was

Joanna Radin //

“Choices made in the past have consequences
for the present, and what might have seemed ethical
			
in one place and time will change.

Mechanical refrigeration replaced consumer iceboxes in
the 1930s—before that, commercial refrigerators were
as likely to catch fire, explode, or leak toxic gas as they
were to keep things cold—but the technology didn’t take
off in the scientific world until World War II.
Soldiers scattered across the globe in need of blood
transfusions led to the creation of a “cold chain” for blood
transportation. This chain moved stateside blood donations to soldiers on the front lines, requiring not just
fridges and freezers at collection sites, but also something
to keep blood cold in transit: dry ice and liquid nitrogen.
Yale medical historian Joanna Radin, Ph.D., found that
by the 1960s, scientists had reversed the flow of these
cold channels, using the infrastructure devised during
wartime to learn more about human biology. Blood collected from remote populations around the world could
be shipped to high-tech laboratories for analysis, said
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opened at Yale in 1960. The WHO chose John Rodman
Paul, M.D., to direct it.
Paul, chair of the Section of Epidemiology and
Preventive Medicine at Yale, had used blood samples
to study the spread of diseases like polio and was an
early proponent of freezing biological specimens. In
the 1940s, while investigating antibody patterns in
Eskimos in northern Alaska, he froze serum samples
so that he could reanalyze each one as tests for newly
discovered antigens became available. After more than
a decade of studying the same samples, Paul still found
the frozen serum to be a fruitful source for epidemiological research. “Indeed,” he wrote in 1961, “the epidemiologic story which this work has gradually been
unfolding is not yet finished.”
The reference serum bank at Yale, whose rise was
the subject of Radin’s research, quickly became a hub

Cell lines offer
a look into the past
for the advancement of epidemiological research. In
1966, Alfred S. Evans, M.D., M.P.H., professor of epidemiology, took over as the second director of the
bank. In that year alone, more than 21,000 serum
samples were handed out to scientists who wished to
study them. Before the decade was out, the Yale collection had grown to over 25,000 individual samples.
Yale could no longer house the substantial collection,
and the bank moved to a building owned by the New
Haven Cold Storage Co. By the 1990s, when the collection moved from Yale to the National Cancer Institute
in Bethesda, it contained over 50,000 unique serum
samples—and untold insights into the infectious and
chronic diseases of the past and present.
A prescient WHO report released in 1959—the same
year the Bantu man’s blood was collected and frozen—
stated: “If samples of the sera collected in these surveys
are stored in such a way as to preserve antibodies, it
will be possible to examine them in the future and so to
determine the past history of infections as yet unknown
and to follow more clearly the changing pattern of communicable disease all over the world.”
Two decades later, HIV emerged as a devastating
pathogen. In the early 1980s, young, otherwise healthy
people the world over began to waste away, dying of
infections that usually felled only the old: tuberculosis, bacterial pneumonia, cryptococcosis, and herpes
among them. Eventually, researchers discovered that
HIV was at the heart of this immune system failure.
Scientists sought the origins of this viral invader, hoping that understanding where the virus came from
might provide clues for a cure or, at the very least,
a way to contain it. In 1998, researchers from The
Rockefeller University tracked it down to a freezer at
Emory University in Atlanta. The freezer held more
than 1,000 blood samples collected in the Congo in
1959 for a study of an inherited blood disorder common among some Africans. Once HIV was isolated as
the cause of AIDS, an Emory scientist told a colleague
about those samples. Only one sample, belonging to a
Bantu man from a riverside market village, tested positive for HIV antibodies, making it the oldest biological
trace of the disease ever documented.
With this and other preserved HIV-positive tissues, researchers used the known mutation rate of the

In the early days of genetics research, it took a lot of DNA to
look at one polymorphism, so the Kidds transformed their
blood samples from a hodgepodge of cells and proteins
into immortal cell lines from which they could extract DNA
whenever they ran low. To create cell lines, the pair infect
blood cells with Epstein-Barr virus, a common human
herpesvirus. Once inside the cell, the viral genome makes
its way into the cell’s nucleus and begins creating copies of
itself. As the virus replicates, it produces proteins that provoke the human cells to proliferate indefinitely. The Kidds
freeze each cell line until they need the genes for research.
They use chemicals to break open the cell walls, spilling out
the cellular structures and DNA alike, then use a centrifuge
to separate the genetic material from the debris. In addition to being a source of DNA, the cells are also potentially
useful as living cells for a variety of research questions. To
date, the Kidds have collected samples from 55 populations
throughout the world and created nearly 2,600 cell lines.

virus to approximate when the epidemic began. By
2008, scientists had estimated that HIV crossed over to
humans from chimpanzees somewhere in southeastern
Cameroon a century earlier, about 1908. And a greater
understanding of both the origin of the virus and its
mechanisms of action has contributed significantly to
medical advances against the disease.

a q u es ti o n o f o w n er s h i p

The WHO didn’t advocate preserving biological samples
just because they might come in handy in the future,
Radin has shown; the agency was equally interested in
preserving the past. Frozen blood samples could also
serve as permanent genetic snapshots of indigenous
populations that began disappearing almost as soon as
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they were discovered, and help to unravel humanity’s
evolutionary history.
By the mid-20th century, globalization was heating
up. The WHO envisioned a future of both environmental and cultural upheaval, in which lands and peoples
would be overwhelmed by the spread of Western
influences. According to Radin, the WHO considered
so-called “primitive” island populations to be unique
laboratories “in which nature had run experiments on
humans for thousands of years.”
These populations provided unique windows into
our evolutionary past, and according to the WHO, they
were also vanishing. Scientists scrambled to collect
blood samples from remote and endangered peoples to
preserve their genetic fingerprints. Yale would become
the home of a second massive collection, different from
Paul’s bank of serum samples because it contained cell
lines. Today, one of the largest collections of anthropologically relevant cell lines resides in the Kidds’ lab,
according to Radin.
“Some of these samples are never going to be collectable again,” said Ken Kidd. Their collection contains samples from diverse populations, from the Atayal tribe in
Taiwan to the Zaramo people of Tanzania. But these isolated populations are not necessarily dying off, as WHO
officials imagined they might, but rather integrating into
societies that have grown up around their territories.
According to Ken Kidd, whether indigenous groups are
dying or assimilating, such change “obliterates a window
into the past.”
Still, many of the cultures that the WHO expected to
disappear are alive and well. “Cold War-era scientists’
vision of the future did not include a world in which the
barriers to collecting such blood would come from these
peoples themselves,” wrote Radin.
There are many reasons why a group would object to
how their blood samples might be used. The Havasupai,
a community that lives deep within carved cliffs of the
Grand Canyon, is a prime example. In the 1960s, rates of
diabetes among tribe members mysteriously skyrocketed.
Thirty years later, a geneticist at Arizona State University
in Phoenix parsed the tribe’s DNA for the cause. Roughly
100 tribe members volunteered blood samples, but when
they later learned that those samples had been used for
other studies, including one that proposed a theory of the
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tribe’s origins that contradicted the group’s own creation
myth, they balked. After a lengthy legal battle, the university paid reparations and returned the blood samples.
Ten years after their cells had been immortalized in
a cell line, another group of Native Americans, whom
the Kidds prefer not to name for legal reasons, asked that
their cells be returned to them even though they had
originally given full informed consent. But because the
process of transforming a cell into a cell line involves
infecting it with a virus, those cells are designated a biohazard—the Kidds couldn’t ship them to anyone without
a functioning lab and a qualified technician. The group
settled for having the cell lines and DNA destroyed. “The
head of the Human Investigation Committee here at Yale
watched us thaw out and destroy all the frozen cell lines,”
said Ken. The DNA that had been isolated from those cells
was “cooked” in an autoclave.
“That was painful,” Ken said of the ordeal. “Oh, it was
heartbreaking,” added Judy. Today, the Kidds’ entire collection faces an uncertain future.
Judy retired in 2011, and Ken is likely to retire by 2016.
It’s unclear what will become of the cell lines they’ve
spent their careers studying. “It’s a matter of interest and
responsibility and money,” said Judy. “There are lots of
things we could do that wouldn’t make me feel as good
as keeping those cell lines right here at Yale.” Ideally, the
collection will remain at Yale, perhaps in the Peabody
Museum as a frozen gallery of sorts, where a technician
can watch over the cells, monitor liquid nitrogen levels,
and send cell lines to qualified researchers. The scientist
or organization, at Yale or elsewhere, who takes responsibility for the cells will be responsible for ensuring both
the immortality of the cells and the immortality of the
promises that were made to donors when they gave their
blood to research. If both needs aren’t met, all 2,600 lines
will have to be destroyed.
If the cells remain in the freezers, they could yield
untold knowledge for future generations of researchers.
The issue remains, however—the needs of science may
conflict with the social and ethical questions raised by
the maintenance of cold blood. “They are not always
likely to be in alignment,” Radin said. “Choices made
in the past have consequences for the present, and
what might have seemed ethical in one place and time
will change.” /yale medicine
Kate Wheeling was Yale Medicine’s 2014 writing intern.

Was pharaoh’s
odd appearance genetic?
A K H E N AT E N, T H E E G Y P T I A N RU L E R

who was husband to

Nefertiti and father to Tutankhamen, is best known for two
things: he was the first historical figure to embrace monotheism, and he was “one funny-looking pharaoh,” according
to Irwin M. Braverman, M.D. ’55, HS ’56, a Yale dermatologist
with overlapping passions for art and medicine.

I S TO C K PH OTO.CO M PH OTO

Scholars have attributed this odd
appearance—androgynous, with wide
hips, an elongated head, almond eyes,
square jaw, and womanly breasts—to
various causes. Early representations

of the pharaoh depict a normal
head and body, but after Akhenaten
embraced the Sun-disk god, Aten, as
the one and only deity, his gender in
sculptures and carvings became more
ambiguous. His changing appearance has led to speculation that the
depictions were metaphorical, meant
perhaps to portray Akhenaten as the
father and mother of all humankind.

Opposing explanations suggest that the changing images were
realistic and reflect a genetic disorder. Braverman is firmly in this second camp. “This is not just artistic
license,” says Braverman, professor
emeritus of and senior research scientist in dermatology and co-author
of a 2009 paper in the Annals of
Internal Medicine that examined
the issue. With colleagues from
Maryland and Pennsylvania, he
proposed that two familial disorders—aromatase excess syndrome
and sagittal craniosynostosis
syndrome—were the most likely
candidates. A third possibility is
a mutation in the gene for a class
of enzymes that was responsible
for both the cranial and endocrine abnormalities of members of
Egypt’s 18th dynasty. Braverman
would like to settle the question
through DNA analysis of mummified remains, but attempts to obtain
samples have been unsuccessful.
If Akhenaten passed down gene
mutations that conferred his strange
physical characteristics on his progeny, he did not pass on his most
notable quality, belief in only one
god. Despite the pharaoh’s singleminded concept, the Sun-disk did
not endure. After Akhenaten’s death
in 1336 BCE, the cult that he had
established faded from prominence,
and Egypt returned to the worship
of the many gods and goddesses that
had preceded Akhenaten.
—Michael Fitzsousa
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Building
a biobank
… a million veterans at a time
By Bruce Fellman | Greg Hall Illustration
The exhortation to “enlist” wasn’t as dramatic as that
of the famous “I Want You” poster featuring a red-,
white-, and blue-clad Uncle Sam, but William Koob, 71,
a seaman’s apprentice in the early 1960s, found the call
almost as compelling. Koob, a bank auditor, was semiretired and working at the VA Connecticut Healthcare
System campus in West Haven when he heard about an
initiative called the Million Veteran Program (MVP).
Launched by the Department of Veterans Affairs in
2011 and co-directed by a Yale faculty member and a
School of Medicine alumnus, the MVP hopes to recruit
a million veterans over the next five to seven years.
Genetic information and electronic health histories of
that “mega-cohort” of vets will reside in an enormous
biobank for scientists and clinicians exploring the connections among genes, the environment, military service, and disease.
To date, said John Concato, M.D., M.S., M.P.H. ’91,
professor of medicine and one of the project’s two
principal investigators, nearly 350,000 veterans have
signed up. Koob was one of them.
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“All MVP required was giving a blood sample, allowing
my VA health record to be accessed, and filling out health
questionnaires—and I quickly realized how valuable this
information could be,” said Koob. “It was another opportunity to serve, and I was happy to contribute.”
The project, it turns out, is not the only endeavor
looking for a million good men and women. As part of
his 2016 budget, President Barack Obama announced
in January that he wanted to invest $215 million to create the Precision Medicine Initiative (PMI): a massive
biobank—compiled from both emerging and existing
databases (possibly including data from the MVP)—of
genetic information and electronic medical records of a
representative sample of U.S. citizens, a million strong.

		

Michael Gaziano //

“Just like the Hubble Space
Telescope opened up ways of seeing
		 the universe … we think that
MVP will allow us to explore
			 the genomic universe.

’’

The PMI, said the president, could “lay a foundation for
a new era of lifesaving discoveries.” (Richard P. Lifton,
M.D., Ph.D., chair and Sterling Professor of Genetics,
has been named co-director of the PMI.)
The president’s initiative, if funded, would allow
researchers to cull genetic secrets about the origin
and development of physical and mental disorders—
insights that might lead to more custom-tailored and
cost-effective treatments, particularly for cancer. The
MVP, while its goals are similar, is targeted toward
a more specific population—a group whose “can do”
attitude and eagerness to enlist is typical, said Concato,
who directs the VA’s Clinical Epidemiology Research
Center in West Haven and has conducted extensive
research on prostate cancer epidemiology and screening. “When you consider that this project is not going
to benefit any of the participants directly,” he said,
“their altruism is very impressive.”
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None of the information an individual provides,
including the fruits of the DNA samples, goes into the
veteran’s personal medical record. Instead, this nationwide “big data, big science” effort will allow researchers
and clinicians “to better identify those at risk of getting
a disease, those who might be prone to do worse with
that particular ailment, and what medications might
work best as treatment,” said Concato. “This is the
promise of personalized medicine, and MVP stands to
greatly improve our ability to provide it.”

ex pl o r i n g th e g en o mi c u n i v er s e

It’s too early to know what discoveries might be made,
say Concato and the other principal investigator,
J. Michael Gaziano, M.D. ’87, M.P.H., a professor of
medicine at Harvard. Advances in understanding
the interplay of genes and such illnesses as cancer,
diabetes, and heart and circulatory problems, and
such mental illnesses as service-related post-traumatic
stress disorder (PTSD) are possible long-range program benefits.
“Just like the Hubble Space Telescope opened up
ways of seeing the universe that Earth-bound telescopes couldn’t provide, we think that MVP will allow
us to explore the genomic universe,” said Gaziano,
scientific director of the Massachusetts Veterans
Epidemiology Research and Information Center, chief
of the division of aging at Brigham and Women’s
Hospital, and director of the VA Boston Healthcare
System’s Geriatric Research and Education Center.
The MVP is one of several similar efforts around the
world, among them biobanks in the United Kingdom
and China, each of which has about 500,000 participants, and at Vanderbilt University and Kaiser
Permanente, which include about 175,000 and 200,000
people, respectively. The MVP, if it meets its target, will
be the largest among them.
All these efforts link at least two streams of genetic
and medical data; the MVP links three. The first is
genomic information gleaned from different DNA
sequences: general genotyping; the sequencing of just
the coding part, or exome, of the genome; or, in a small
number of cases, whole-genome sequencing. The second stream includes health and treatment information
from each vet’s electronic medical record. The third
part, unique to the MVP, is a health and lifestyle survey
that includes questions about military service which
will give researchers a better understanding of possible
genetic underpinnings of conditions like PTSD that
might affect people in the armed forces.

“MVP couldn’t have been built without the existing
VA research infrastructure,” said Concato, who, with
Gaziano, directs a staff of about 20 in West Haven and
Boston, with key support from the Office of Research
and Development in Washington, D.C.
One key to the program’s eventual utility is the VA’s
reach: data are being collected at about 50 VA health care
facilities around the country, each of which has two staff
members dedicated to the MVP. Another is the availability of its pioneering electronic medical record, which
can look backward and forward in time and follow vets
wherever they live. A third aspect is data security—the
VA made security the highest priority from the moment
it started its EMR implementation. Last, recent developments in information technology, from automated biostorage data retrieval to computer analytic capabilities,
allow researchers to manage massive amounts of data.
“Maybe the biggest enabling technology is having a
chip that allows us to do cheap genetic testing,” said
Gaziano. “We can now look at the genetic variation in
about 750,000 places on a person’s genome for $75—that’s
$52 for the chip and the rest for processing—and this ability to generate data, coupled with the information we’ll
get from hundreds of thousands of vets, will let us start
to answer questions we couldn’t have even asked before.”
One area of interest is an aging population. “We
hope that MVP will be a pluripotent resource that can
be used by researchers and providers to look at how
to best deal with that group, from studies of frailty
to understanding variations in medication-related
enzyme metabolism,” said Gaziano.

a t th e beg i n n i n g o f a re v o l u t i o n

Like Concato, Gaziano is no stranger to big-data projects.
“I’ve been working in the large cohort business since I
arrived at Brigham and Women’s in 1988,” he said. He’s
had leadership and research roles in the Brigham and
Women’s-based Physicians’ Health Study, which has followed a cohort of more than 30,000 doctors in the United
States to examine a variety of health questions, as well as
the Nurses’ Health Study and the Women’s Health Study,
both of which are affiliated with Brigham and Women’s
and have enrolled cohorts of more than 100,000.
“While it builds on earlier work,” Gaziano said of
the MVP, “it’s really something new.”

Early epidemiological studies were primarily descriptive and involved small numbers of subjects or issues,
such as the relationship of smoking to lung cancer. The
famous Framingham Heart Study (FHS) in Massachusetts
has since 1948 tracked 5,000 adults to ask fundamental
questions about the epidemiology of cardiovascular disease. The FHS used multivariate computer modeling to
examine the impact of a half-dozen risk factors.
But with 20,000 to 25,000 protein-coding genes
in the human genome, a cohort needs hundreds of
thousands of people so that scientists can determine
“how genes interact with other genes and environmental factors to contribute to health and disease,” said
Gaziano. “There are enormous numbers of variables,
so we need mega-cohort studies like MVP to solve the
signal-to-noise problem that genetics gives us. We’re at
the beginning of a very exciting revolution.”
Two “alpha” studies have begun testing the biobank’s ability to deliver useful information. Concato,
Gaziano, and their colleagues have mined the database
for mentally healthy vets who can serve as a control
group for comparison with 9,000 vets with schizophrenia or bipolar disorder. “The pending genomic
analyses can advance our understanding of the etiology of, and treatments for, two major psychiatric
disorders,” the researchers wrote last year in the
American Journal of Medical Genetics.
The second alpha test, co-directed by Joel Gelernter,
M.D., the Foundations’ Fund Professor of Psychiatry
at Yale, is using the biobank to find a cohort of vets
with PTSD to compare with an MVP-assembled control group without the disorder. The hope is to identify
genes that increase the risk of this often-devastating
condition and to develop more effective methods of
detecting and treating it.
Last year, MVP leaders issued a nationwide call
for proposals, said Concato. About 20 have survived
the first review round, and those approved will investigate an array of topics from heart disease and lung
cancer to mental health disorders and problems
with water metabolism. Funding decisions will be
made later this year.
“It’s important to remember that MVP is an infrastructure project,” said Concato. “Our role is to help
design the program so that researchers can use the
biobank effectively, securely, and ethically, and
have the right information available to ask the right
questions.” /yale medicine
Bruce Fellman is a freelance writer in North Stonington, Conn.
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Whispers on the medallion,
		 the Society of Wu,
and Frisbee on the lawn
WHAT DO YOU HAVE TO DO to get into the School of Medicine?

According to Dan Okin, a fourth-year medical student, a superstition handed down by students directs you to the medallion
beneath the rotunda in the Cushing/Whitney Medical Library—
where you stand and whisper your name and the phrase “Please
let me in!” Thanks to architectural magic, they’ll hear you in the
admissions office, which once occupied space above the rotunda.
“Our tour guides on interview
day have the applicants stop in the
center of the rotunda and say a
few words to hear the mystical
echoes,” said admissions director
Richard A. Silverman.
If you ask alumni of the School
of Medicine which traditions they
remember best, they often mention
venerable and well-established ones
first—donning a white coat for the
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first time; honoring donors who
willed their bodies to the anatomy
lab; or raising money for the homeless in an annual auction. But
quirkier traditions, customs, and
habits have appeared through the
years at Yale Med, too. Passed down
from student to student, these
activities continue to evoke fond
memories. Some have survived;
some haven’t, though we don’t
always know why.
For a time, students would sneak
into the Brain Room, locked deep
within a subbasement of Harkness
Hall. A historic collection of brains

preserved by neurosurgery pioneer Harvey W. Cushing, M.D.,
was moved there in 1979, along
with haunting photographs of his
patients. The collection was forgotten for decades except by students
in the know, who would break the
lock or kick in a door panel to get in,
then add their names to a graffitilike sign labeled “Brain Society.”
Brain Room expeditions ended
after the collection was spruced up
and moved in 2010 to the Cushing
Center, a dedicated space within the
medical library.
Some student customs were very
much of their time. In the late 1950s,
recalls Malin Dollinger, M.D. ’60,
students sought birth-control
advice from ob/gyn fellows living
in Harkness dormitory. (Condoms
were then illegal in Connecticut.)
He and his classmates used the
dormitory lawn to play with a
newly invented toy, the Frisbee.
Years later, Jilda N. Vargus-Adams,
M.D. ’95, and her class gamboled on
a Wham-O Slip ’n Slide there after
exams. (A 1993 national recall, with
reports of quadriplegia in adults too
tall to dive onto the toy, may have
dampened enthusiasm for the slide.)
Alcohol has given rise to traditions both raucous and not. In the
1990s, for instance, the Society of
Wu (why it was so named has apparently been lost to the ages) held a
keg party in the Harkness basement
just before exams. “The Yale system
would dictate that you not take tests
too seriously—surely you could go
and partake in the Society of Wu
the night before,” Vargus-Adams
explained. (The Society seems
to have mysteriously disbanded
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before this writer matriculated
in 2000.) The same philosophy
invested Thursday night dances
at the Graduate and Professional
Students Center at Yale, also known
as GPSCY. After late nights at GPSCY,
she recalled, whether from fatigue
or hangovers, attendance and
energy were low at Friday morning
anatomy lab.
More prosaically, Dollinger’s
classmates volunteered for paid
studies at the Yale Center of Alcohol
Studies on the main campus. They
had to phone for rides back to the
medical campus when they became
too drunk to walk. That tradition
presumably ended when the center
relocated to Rutgers in 1962.

Harkness wasn’t the only locus
of party culture. In the early 2000s,
the Pink House, an institution of
sorts in the East Rock neighborhood that housed a revolving and
brotherly clan of medical, law, and
physician associate students, hosted
monthly rotation-switch parties.
Alas, Roberto Lugo, M.D. ’04, who
lived in that house, noted sadly on
a recent reunion visit that it is no
longer pink.
Yale Med’s longest-standing
tradition, of course, is the Second-

Year Show. Begun in 1949, it has burgeoned into a satirical extravaganza;
the camaraderie and dedication it
inspires make it the cherry on top of
the Yale system. What few students
these days know, though, is that the
show began as a fourth-year activity.
(The second-year show arose in the
mid-60s; by the end of that decade,
the fourth-years ceded the stage.)
The timing of the fourth-year
show had its advantages, explained
Victor A. Altshul, M.D. ’60. “We
gave it just before graduating, so
that the attendings we were lampooning couldn’t retaliate,” Altshul
recalled. “And boy, did we ever give
it to them.”
—Jenny Blair, M.D. ’04
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History
of heredity
By John Curtis | Jennifer Stockwell Illustrations | Benjamin Hecht Photos
L O N G B E F O R E A N YO N E D I S C OV E R E D D N A , chromosomes, or genes,

humans had figured out something important about the world around us.
When we turned from hunting and gathering our food to growing and
raising it, we realized that we could breed plants and animals to bring out
desirable traits. Wild grasses became wheat under human cultivation; we
also domesticated and bred cows, pigs, and sheep to produce food, leather,
and wool. And we also noted similarities between parents and offspring
without knowing what causes these similarities. The concept of heredity
preceded the science of genetics, but it is genetics that explains why all living species carry inherited traits and qualities. This timeline lists some of
the key advances in thinking about heredity and genetics.
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During the Neolithic era, about
12,000 years ago, as humans
move from hunting and gathering
to growing their food and raising
animals, they learn to breed
desirable traits into wild grasses
(1) and domestic animals.

1
2

In the fifth century B.C., Hippocrates (2) speculates that
“seeds” are produced by various
body parts and transmitted to offspring at the time of conception.
3

4

Theophrastus (3), a Greek scholar
of the late third century B.C.,
who studied under Aristotle
and is considered the “father
of botany,” proposes that male
flowers cause the ripening of
female flowers.
Aristotle (4) proposes in the
fourth century B.C. that male
semen and female menstrual
blood mix at conception and
that offspring receive traits from
both mother and father.

5

Abu al-Qasim (5), an Arab physician
from about A.D. 1000, who is
considered the father of modern
surgery, describes the hereditary nature of hemophilia.
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William Harvey (6), a seventeenthcentury London physician,
wonders why offspring sometimes resemble the father,
sometimes the mother, and
sometimes progenitors both
maternal and paternal.
During the late seventeenth
century, the Dutch lensmaker
Antonie van Leeuwenhoek (7)
describes “animalcules” in the
semen of humans and animals.

6

7

8

Around 1800 the notion of
heredity enters debates among
physicians, animal breeders (8),
and naturalists, and becomes a
fundamental concept of biology.

9

The Austrian monk Gregor Mendel
(9) describes patterns of inheritance in peas in the mid-1800s,
but his theories are ignored, to be
rediscovered only in 1901.

11

10

In the mid-nineteenth century,
the English naturalist Charles
Darwin (10) proposes the theory of
evolution, with natural selection
and heredity as its mechanisms.
In 1869 a Swiss physician, Friedrich Miescher (11), discovers a
microscopic substance in pus
obtained from discarded surgical bandages. He isolates DNA
from those samples and calls it
“nuclein” because it resides in the
nuclei of cells.
Hugo de Vries (12), a Dutch botanist and geneticist, postulates in
1889 that “inheritance of specific
traits in organisms comes in
particles,” and calls the particles
“(pan)genes,” a term that would
later be shortened to gene.

30 yalemedicine.yale.edu

13
12

14

15

16
17

In 1902–03, Walter Sutton (13),
an American physician, and
Theodor Boveri (14), a German
biologist, independently propose
the chromosome theory of inheritance: chromosomes, which
segregate in a Mendelian fashion,
are hereditary units.
William Bateson (15), an English
geneticist, coins the term genetics in 1905.
In 1931, Barbara McClintock (16),
an American pioneer in cytogenetics, provides the first
proof that genes are physically
positioned on chromosomes.

19
18

20

In 1944, Oswald T. Avery (17),
Colin MacLeod (18), and Maclyn
McCarty (19) conducted an
experiment at the Rockefeller
Institute that isolated DNA as the
substance that causes genetic
transformation.
James Watson (20), Francis Crick
(21), Maurice Wilkins (22), and
Rosalind Franklin (23) elucidate
the structure of DNA at the University of Cambridge in 1953.

22
21
23

2001–2003: The first draft sequences of the human genome
are released by the international
Human Genome Project and
Celera Genomics in February
2001; two years later, the Human
Genome Project is considered
complete, with 99 percent of the
genome sequenced to a 99.99
percent accuracy.
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So you’ve decided to
become a doctor
A P P E N D I C I T I S L A N D E D X I A N G ( AV E L I N E) L I

in the emergency

room during her junior year at Bowdoin College, where she was
majoring in biochemistry. Her parents, both physicians, were
living halfway around the world in China and she was frightened
and unsure about what was happening. After the appendectomy,
complications required a second surgery and two more weeks
in the hospital. During her recovery Li gained firsthand insights
into the needs of patients. Prior to her illness, she’d been exploring medicine to see whether she wanted to become a doctor.
Becoming a patient helped confirm her decision.
While Li was recovering, Nidharshan
Anandasivam, also a college junior,
was studying biomedical engineering at MIT and exploring volunteer opportunities to see whether
medicine was in his future. Having
injured his ankle several times while
playing basketball, Anandasivam
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wondered whether he would be able
to integrate his passions for sports,
health, and science into a career. His
physician parents had encouraged
him to pursue his interests in college
and see where they led.
What influences a child of physicians to choose a career in medicine? For Li and Anandasivam,
students in the Class of 2018, a
future in medicine was not a foregone conclusion even though their
parents are physicians.

Fascinated by high school biology and the human body, Li’s
interest in medicine grew as she
sought opportunities to engage
patients and observe the physician’s role. During high school she
volunteered at the Veterans Health
Administration and worked with a
physician on reducing patient waiting times. “That experience had a
big impact,” she said. “Seeing how
happy patients were to see their
doctor and observing the mutual
trust involved in the doctor-patient
relationship was inspiring.” In
college, she volunteered at a local
hospital and the American Cancer
Society. “Each new volunteer experience confirmed that I wanted to
become a doctor,” Li explained.
Li’s maternal grandfather had
been a doctor and her maternal
grandmother had been a nurse.
But her father, a neurologist, and
her mother, a pediatrician, had no
expectation that Li would go into
medicine. In fact, because of the
consuming nature of the profession,
they initially tried to dissuade her.
Li didn’t grow up seeing her parents working with patients, because
they lived in Canada and the United
States, where neither parent was
licensed to practice. They instead
did genetics research, and when
Li started college they returned to
China to practice medicine. During
visits to China, Li observed the very
limited time her parents could spend
with their patients. She valued the
patient-physician relationship and
was determined to practice medicine
in a different way. “China’s large
population means my parents don’t
have time to do what I’m learning at

JOHN CURTIS

Yale—the patient-centered interview,”
she explained.
Anandasivam’s family is from Sri
Lanka, but he grew up in Rancho
Viejo, Texas, where his father is a
nephrologist and his mother is an
internist. During high school, strong
interests in math and physics pointed
him toward engineering. But his
college classes, research, and volunteer activities increasingly pulled
him toward medicine. Anandasivam
carefully chose volunteer opportunities that exposed him to different aspects of medicine, including
working as an EMT Basic with MIT’s
EMS service and participating in the
MIT MedLinks program, a dormbased peer-to-peer health advocacy
group. He also worked with LIFT, a
community service program, where
he enjoyed helping people solve
problems and find resources. “My
experiences in college serving the
community were the driving forces
in my choice,” he explained.
Anandasivam said that his parents and especially his grandmothers, who lived with his family
and helped raise him and his younger
brother, modeled the importance
of service. “They were ‘service first’
people and that had a big effect on
me,” he said. As he experienced the
confirmed her decision. His engagservice side of medicine in concert
ing bedside manner provided a role
with the intellectual side, it became
model for the type of doctor she
clear that medicine was a good fit.
wants to become. Anandasivam
The influences that led Li and
said his parents’ enthusiasm for
Anandasivam to choose medicine
their profession helped him see
were multifaceted. They enjoyed
the intellectual challenges of medicine and valued serving others.
For Li, meeting outstanding clinicians—including the surgeon who
performed her second surgery—also

Nidharshan Anandasivam and Xiang
Li are both children of doctors. How
much did their parents infl ence
their decision to enter medicine?

how rich a life in medicine could
be. “I would’ve been less enthusiastic about it if my parents’ work
compromised their ability to
perform their other important
responsibilities,” he added. “But
they spent a lot of time with us and
showed us that it’s possible to have
an engaging career and fulfill your
role as a parent and spouse.”
—Katherine L. Kraines
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When a gene
goes awry
Medical and genetic sleuthing
unravel the mystery of an infant’s
death and a father’s fevers
By Jill Max | Harold Shapiro Photos

Susan Kazmierczak, Neil Romberg,
Richard Lifton, and Mustafa Khokha
were part of a team of clinicians
and scientists who determined that
a defective gene was behind a
family’s health problems.

When Mustafa K. Khokha, M.D., first saw the Drewniak
baby in the summer of 2012, he was worried. The baby
boy, first treated at Norwalk Hospital, had a high fever
and severe diarrhea that was getting worse. Clinicians
at Yale-New Haven Hospital’s Pediatric Intensive Care
Unit were frantically trying to keep up with fluid
losses. Infection, the most likely culprit, had been
ruled out. Khokha, associate professor of pediatrics
(critical care) and of genetics, wondered whether an
underlying genetic cause would explain the baby’s
condition, and called Richard Lifton, M.D., Ph.D., chair
and Sterling Professor of Genetics. Genome sequencing,
Lifton felt, might yield clues to the infant’s ailment.
Both Lifton and Khokha thought that the baby might
have a new genetic mutation—a de novo mutation—
since both of his parents were healthy.
They used high-throughput exome sequencing to
analyze the 21,000 protein-coding genes in the
genomes of the baby and both his parents. Meanwhile,
Neil D. Romberg, M.D., assistant professor of pediatrics
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When a gene goes awry

(immunology), examined the baby for a rash. Romberg
recognized it as the first sign of a massive immune
response, and lab tests indicated that the baby had widespread inflammation. “Inflammation in the absence of
infection is usually a genetic problem,” said Romberg.
The Yale Center for Genome Analysis rushed the
sequencing and analysis. Completed in just a few
days—a heroic effort—test results arrived the day after
the 3-week-old baby died. The analysis found no de
novo mutations that explained his illness.
A few days after the funeral, Erik Drewniak was still
reeling from the loss of his infant son when he came
down with a fever. He didn’t think it was anything to
worry about. All his life he had had fevers that spiked
as high as 106 degrees. But this time the fever persisted
and he was having difficulty breathing. Concerned
about pneumonia, he went to the emergency room. At
Norwalk Hospital, Drewniak’s condition deteriorated.
He went into respiratory failure and was put into a
medically induced coma so that he could be intubated.
Soon afterward, he was in intensive care at Yale-New
Haven Hospital where tests showed he was suffering
from inflammation and hemorrhaging of the bowels,
lungs, and brain. His condition was serious, but he
improved and went home nine weeks later.

a c l u e i n a r a n d o m mu t a t i o n

With every sequencing of a patient’s genome, new,
previously unseen protein-altering variants in genes
emerge. These random mutations are due to variation
in the human population. When Romberg suggested
that the baby might have had an autoinflammatory
disease, Lifton invited him to his lab to look at a list of
variants. Romberg recognized a mutation in NLRC4, a
gene involved in the innate immunity pathway—the
first line of defense in the body’s response to infection—that could contribute to disease, although it had
never been shown to have such an effect. That same
day, while gathering information about the baby
from Norwalk Hospital, Lifton’s research coordinator
learned that Erik Drewniak was hospitalized with a
severe illness. For Lifton, that was an “aha” moment.
“We recognized at that point that the variant in NLRC4,
which was shared between the father and the baby, might
link their diseases,” he said. It turned out that Drewniak
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and his infant son shared a genetic mutation causing an
illness that had never before been described.
Advances in genomic sequencing technology, combined with clinical expertise and biochemical analysis,
allowed Yale doctors to identify the mutation, home
in on the pathway it affected, and devise a personalized therapeutic strategy that saved Drewniak’s life.
Using whole-exome sequencing to diagnose diseases
is increasingly proving to be both useful and practical. Five years ago it would have cost about $10,000 to
do the exome sequencing performed on the Drewniak
family; today it costs about $500. Not surprisingly,
this service is rapidly expanding. Last year, Yale
sequenced about 500 patients; this year about 1,000
will be sequenced. The Drewniaks’ experience is just
one example of the ways in which personalized medicine, which is being supported by President Obama’s
recently announced Precision Medicine Initiative, is
gaining ground.

pa s s i n g o n a g en e

To confirm that the Drewniaks’ illnesses were caused
by the newly identified mutation, the Yale team
sequenced other family members, including Erik’s
parents and two children who are half-siblings of his
infant son. While his parents and daughter do not have
the NLRC4 mutation, the sequencing showed that his
son, now 7, does. Like his brother, he was hospitalized
as an infant, although in his case it was due to kidney
failure. Like his father—who was also hospitalized as
a baby for a fever and severe diarrhea—he suffers from
periodic high fevers. The mutation was in fact de novo,
but it first occurred in Erik Drewniak, who passed it
on to two of his children. His young son has a 50/50
chance of passing it on to his offspring.
Once a genetic mutation emerged as the likely cause
of disease in three Drewniak family members, the
next step was to understand how a single change in
this particular protein code could wreak such havoc.
“Exome sequencing by itself is not the solution,” said
Khokha. “It’s just the first step.” Romberg enlisted
Barbara I. Kazmierczak, Ph.D., M.D., associate professor of medicine (infectious diseases) and of microbial
pathogenesis, who had been studying NLRC4 in mice.
NLRC4 belongs to a group of intracellular proteins
that react when bacterial toxins breach the cell wall.
Kazmierczak and Romberg’s research showed that the
mutated NLRC4 protein activates a powerful inflammatory pathway that sent the Drewniaks’ immune
systems into overdrive, even though no bacterial

infection was present. “Their system is always on when
it should be off,” said Kazmierczak.
Today, Erik Drewniak is healthy, as he has been for
much of his life. “It didn’t affect me when I was growing up,” he says of his illness. He played in bands and
was on the tennis team in high school, missing only
an occasional event because of a fever. His son is also
relatively healthy. “He does kung fu and other typical
kid stuff,” said Drewniak. But the mutation they share
causes a constant state of inflammation in their bodies
that can become dangerous.
When Erik Drewniak was hospitalized in 2012,
Nikolai A. Podoltsev, M.D., Ph.D., assistant professor of
medicine (hematology), treated him for what appeared
to be hemophagocytic lymphohistiocytosis (HLH),
another disease in which the immune system becomes
overstimulated. Drewniak’s condition, while different, closely resembles HLH and responded to powerful
anti-inflammatory medication and immunosuppressants, which are used to treat HLH.

u n d er s t a n di n g t h e di s ea s e

Now that Podoltsev and Romberg (who treats
Drewniak’s son) know the mechanism of this disease,
they are better equipped to treat it in the future. “Of
course it’s easier to manage him going forward understanding what we’re dealing with,” said Podoltsev. The
Drewniaks’ care involves managing the inflammation and monitoring symptoms. The mutation causes
production of high amounts of cytokines—in this case
interleukin 1 beta—that cue the immune system to start
reacting to an infection, so interleukin 1 inhibitors could
be useful if either of them experiences a flare-up.
Beyond the therapeutic implications of these discoveries, the ability to pinpoint the cause of mysterious
illnesses is invaluable. “When a baby dies of diarrhea, it’s very disturbing because it doesn’t happen
in this country,” said Khokha. “It feels like a failure.”
Being able to tell his parents why their baby died provided some solace. Fortunately for families like the
Drewniaks, diagnosing rare genetic illnesses is becoming more common. “We’ve gotten to the point where
genetic sequencing is fast enough and cheap enough
and we’ve done enough of it, that this is no longer science fiction,” said Romberg.

Erik Drewniak and two of his
children suffered from unexplained
fevers. Doctors and scientists at
Yale discovered the cause—a de
novo genetic mutation.

“It’s clear there will be many more cases like this
one,” said Lifton. Of the 21,000 protein-coding genes
in the human genome, he said, scientists know what
happens when about 3,000 of them are mutated.
“When I’m asked what remains to be done, the answer
is practically everything.” Researchers are beginning to tackle this undertaking. The Yale Center for
Mendelian Genomics is one of three national centers
created by the National Institutes of Health to try to
understand the genetic causes of diseases like the one
in the Drewniak family. The center has identified about
250 new disease genes since it was established in 2012.
Meanwhile, Khokha and his colleagues often
see children with birth defects or unexplained illnesses that they are unable to diagnose. A new program, Pediatric MAP, supported by the Yale School of
Medicine, the Yale Center for Clinical Investigation,
and Yale-New Haven Hospital will allow them to carry
out the research that was done for the Drewniaks on
a broader scale. The hope is that by formalizing the
program, Yale doctors will be able to provide answers
for these families by identifying genetic mutations
and unraveling their biology with the ultimate goal of
developing new therapeutic approaches.
For Drewniak, the knowledge of what caused
his infant son’s death is empowering. “Genetics is something you can latch on to as a definite explanation,” said
Drewniak. “It’s not the environment, it’s not something
you did or didn’t do, it’s genetics. It made me understand
not just him, but all three of us. Everything just came
together and now it all makes sense.” /yale medicine
Jill Max is a freelance writer in Trumbull, Conn.
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The New Haven home of Daniel Colón-Ramos, Ph.D., his wife, Emily
Wang, M.D., assistant professor of medicine, and their triplet daughters is a Tower of Babel. The 4-year-olds Alexandra, Beatriz, and
Caysani speak Spanish among themselves, with their dad, and with
their nanny, and speak Mandarin with their mom. Mom and Dad
speak to each other in English, and each speaks a bit of the other’s
native tongue. Watching how his daughters play and communicate
led Colón-Ramos, associate professor of cell biology, to write an
article for the TEDBlog in December 2012, when the girls were toddlers.
In “On nature versus nature: A neuroscientist knee-deep in diapers
reflects,” he described the lessons he’s learned from his daughters,
how they’ve changed his brain, and the futility of the debate over
nature versus nurture. Since he wrote the article, Colón-Ramos tells
us, what he said then remains true today.

Refl ctions
of a neuroscientist
I COULDN’T HAVE DESIGNED A BETTER EXPERIMENT IF I’D TRIED.

I am a neuroscientist and I am the father of 2-year-old
triplets—two identical and one fraternal. As a professor at Yale
University, I spend most of my time designing experiments,
researching or teaching about the brain and the nervous system.
The rest of my time I spend surrounded by my three daughters.
To understand the dynamics in my household, think terribletwos, and then cube it.
In the quiet sanctity of my lab,
we study how the nervous system
forms during development. In
all animals, from humans to the
tiny worms that we use for our
experiments, neurons connect to
each other and form circuits that
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underlie behaviors. Genes (made
of DNA) underpin many aspects of
development—from how our brain
forms to the color of our eyes.
My identical twin daughters
look identical because they share all
of their DNA; they are essentially
clones of each other. They teethed
exactly the same day, and their
funky hairstyle is not the result of
a visit to a stylist, but of genetics.
Their personalities, however, are not

identical. Not even close. The twins’
personalities, which share 100 percent of their DNA, are curiously
more similar to that of their fraternal sister than to each other.
That certainly came as a surprise
to me. After all, argue all you want
about nurture, but behaviors do
have genetic underpinnings in the
animal kingdom. Take reptiles; soon
after hatching from its egg, a baby
crocodile can hunt dragonflies with
the same dexterity that its parents
can hunt antelopes. Who taught the
baby crocodile to hunt? Genes.
I reflected about this a lot as
I held my newborn daughters in
the nursery room of the hospital.
Human brains at birth do not appear
nearly as impressive as a reptilian brain. For crying out loud, the
tiny nematodes we use in the lab for
our experiments can move around
better at birth than a human baby!
Newborns appear as blank slates.
Are we really a tabula rasa? What
are the roles of nature (genes) and
nurture (our environment) in the
development of our brains, in making us human?
My epiphany came with the
first visit to the pediatrician. She
closely monitored our daughters
as they met, in unison, one developmental milestone after the other.
As a neuroscientist, I knew what
this timely emergence of complex
behaviors meant: it is a hallmark
of preprogrammed brains. But our
preprogrammed brains are not for
hunting dragonflies. The evolutionary pressures that have shaped our
brains are different from those that
have shaped the brains of swampbound reptiles.

HAROLD SHAPIRO PHOTO

We are born into complex societies and quickly have to learn to
negotiate our place within them. My
three kids, the ones playing with
my iPhone, are the same species as
my ancestors, who 40,000 years ago
were figuring out how to sharpen a
rock and fit it into a spear. The Homo
sapiens brain is wired in a very particular way: to allow us to connect to
other human brains.
Our home is testament—a cross
between the Tower of Babel and a
Univisión soap opera. It is filled with
sound, from the tonal Chinese my
wife has taught the triplets to the
slurred Puerto Rican Spanish they
have learned from me. During the
past two years I have witnessed how
each of my daughters has masterfully decoded the complex rules of
language and social interactions in
three very different and overlapping cultural contexts, and simultaneously. They confidently navigate
between languages in a way that
sometimes neither my wife nor I can
follow. Chatty conversation and festive giggles are only one disagreement away from despair and temper
tantrums over a train set, a Crayola,
or a dinosaur shirt. But most meltdowns end with hugs, sometimes all
three at the same time, as they can’t
wait to make up.
My daughters’ desire to connect
is not just cute, it’s a matter of survival. So important is our need to
connect to other human brains that
extreme cases of child neglect have
resulted in developmental problems
not unlike those seen for mental
retardation. These extreme cases tell
us something profound about the
brain. It tells us that even in cases

Emily Wang and Daniel Colón-Ramos speak to each other in
English. Wang speaks Chinese to their 4-year-old triplets,
Alexandra, Beatriz, and Caysani. Colón-Ramos speaks to them
in Spanish, which the girls speak among themselves.

in which normal genetics prime the
brain to connect to other brains, the
absence of human input cripples
brain development. Our brains need
other brains to develop properly.
These seemingly delirious
thoughts of a sleep-deprived scientist are neither new nor original
ideas. Today it is broadly accepted
that trying to separate nature from
nurture is as asinine as trying to
debate whether a cake is made out of
milk or flour. But this is important
beyond a mere academic debate. In
science, extreme cases are used to
understand concepts. If no human
contact during critical developmental periods can cripple brain
development, what are the consequences of reduced stimulation due
to a defective and underfunded educational system? The United States

incarcerates more of its youth than
any other country in the world—
what are the consequences of growing up in a prison? We are social and
codependent animals—what are the
hidden costs to our society when
we ignore the “nurture” part of the
human development equation?
The human brain has over 100 billion neurons—there are more neurons in a single human brain than
stars in the Milky Way. When a parent stares at the lost, unfocused gaze
of a newborn child, they are literally
staring at a constellation of possibilities, at a brain primed through
evolution to connect to other brains,
to devour information, to adapt and
to reach its potential. In truth, I’m
highly trained, but not that special;
we are all born scientists, and our
brains are molded by our favorite
subjects of study, other humans.
And I have the perfect experiment
to prove that—my brain, which has
been transformed by my daughters.
—Daniel Colón-Ramos
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capsule

CLOCKWISE FROM TOP:

Fritz Kahn, a German
gynecologist, conceived
of a series of popular
books, The Life of Man, to
make the science of the
human body accessible
to a broad audience. Kahn,
considered a pioneer in
infographics, composed
the text, and designed
or approved ideas for the
illustrations. In The Will of
Mankind, Kahn provided a
depiction of the functions
of the mind and brain.
An earlier eff rt at illustrating the workings of the
human body comes from
a Japanese artist, Utagawa
Yoshitsuna, in the mid-19th
century. Model for Men’s
Dietary Care, a polychrome
woodblock print, shows a
subject digesting a meal
of fish and sake. As with
Kahn’s illustrations, it uses
the metaphor of workmen
performing familiar tasks
to demonstrate the actions
of the internal organs.
In Man as an Industrial
Palace, Kahn depicted
the human digestive and
respiratory systems as a
chemical plant.

OPPOSITE PAGE:
TOP A French advertis-

ing poster from the early
20th century borrowed
from Kahn’s imagery to
advertise the benefi ial
results of a popular laxative. It appeared around
the time of Kahn’s posters published with Das
Leben des Menschen.
BOTTOM From The Life of
Man, a depiction of the
human respiratory system also uses the visual
analogy of a factory.
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Man as
industrial palace
A view of the human body
in the Industrial Age
By Christopher Hoffman

The nearly life-sized poster
titled Der Mensch als

fled Germany when the

Industriepalast (Man as an

Nazis seized power. The new

Industrial Palace) depicts

regime banned and burned

the human body as a com-

his books. But in an ironic

plex machine, a wonder of

idea of making ideas hand-

twist, Nazi authors plagia-

the industrial age.

some and accessible,” she said.

rized his work and illustra-

Workers stand at power

Today, Kahn is widely

tions, adding chapters on

plant-like control panels and

recognized as a pioneer of

supposed racial superiority.

operate the body’s central

information graphics, the

Kahn later lived in France,

nervous and respiratory

use of images and visual

the United States—gaining

systems. Oxygen and carbon

metaphors to convey infor-

entry with the help of fellow

dioxide travel in automated

mation and ideas. He is

German Jew Albert Einstein—

bucket lines down pipes

often mentioned in the same

Switzerland, and Denmark.

to and from the lungs. The

breath as the Austrian Otto

He died in 1968, his work

heart’s chambers are a pair

Neurath, who at about the

largely forgotten.

of pistons, the stomach a

same time invented isotype,

conveyor belt, and the spi-

the communication of data

displayed at the medical

nal cord a telephone system

through pictographic charts.

library are as fanciful as

with switchboard operators
directing calls.
The arresting image is the

Both men did their most

The other two Kahn posters

Man as an Industrial Palace,

famous work in post-World

his most famous image. In

War I Central Europe, a

one, an operator using a tele-

work of Fritz Kahn, M.D., a

time and place of social and

scope and control panels

German gynecologist who

political upheaval as well as

illustrates how the brain

in the 1920s wrote a series

technological and artistic

tells the finger to press a

of popular books titled Das

innovation. That ferment

doorbell. In the other, a war-

Leben des Menschen (The Life

sparked “a fireworks display

ren of chambers containing

of Man) that strove to explain

of new aesthetic form,” wrote

conveyor belts, storage tanks,

science and medicine to a

Uta and Thilo von Debschitz

and other industrial devices
demonstrates the circulation

broad audience. The colorful,

in their 2013 book, Fritz

intricately drawn diagram

Kahn. In the introduction

of blood and air through

is one of three—all origi-

to the von Debschitzs’ book,

the body.

nally inserts in The Life of

graphic design historian

Man—displayed at the Harvey

Steven Heller likens Kahn to

Cushing/John Hay Whitney

astronomer Carl Sagan in his

medical library in the late

Medical Library in January.

ability to make science acces-

1970s and shown here for

sible to the ordinary person.

only the second time, elic-

“The art of analogy was

ited fascination and delight.

Largely forgotten until
recently, Kahn’s books were
famous for their detailed,

CUSHING/WHITNEY MEDIC AL LIBR ARY ADVERTISEMENTS

Kahn, who was Jewish,

Kahn’s forte,” Heller wrote.

innovative, and aesthetically

“Kahn employed whatever

pleasing illustrations, said

visual trick he could cobble

Wheeler said that the
posters, donated to the

“There’s a kind of awed
response to [them],” she said.
“Visitors ask the same kind

Susan Wheeler, the medi-

together for the end result:

of questions, which is who

cal library’s curator of prints,

popular comprehension.”

did them and what were they

drawings, and historical
posters. “I think he had an

The Life of Man series
made Kahn Germany’s most

for? But everyone expresses
extreme enjoyment of them.”

famous popular science
writer of the 1920s. A terrible
artist, he commissioned
others to render his ideas
into illustrations.
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Bringing new cancer
treatments to the clinic
I N M A N Y WAY S ,

Patricia M. LoRusso, D.O., has realized one of her main

missions in life—bringing the latest therapies to people with advanced
cancers through clinical trials. For many patients, a few months can
make a difference and help them get to the next new treatment.
“We saw so many patients die
of melanoma within a couple of
months of phenomenal immunotherapies going into clinical
investigation,” said LoRusso,
who joined Yale Cancer Center in
August 2014 as associate director
of innovative medicine. “It isn’t
over until it’s over, and we often
don’t know what the next drug
is going to offer.”
Among her accomplishments, LoRusso heads one of
the first multi-institutional
investigator-initiated personalized medicine clinical trials,
in collaboration with national
melanoma leaders, as part of her
role as co-leader of the Stand Up
to Cancer/Melanoma Research
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Alliance Melanoma Dream Team.
She came to Yale from Wayne
State University’s Barbara Ann
Karmanos Cancer Institute,
where she was director of the
Phase I Clinical Trials program
and part of the Eisenberg Center
for Translational Therapeutics.
At Yale she sees her role as
a mix of clinical research and
translational medicine, in which
she can apply her experience
developing novel drug therapies
and designing clinical trials.
For LoRusso, bringing novel
therapeutics to the clinic is
highly personal. She was still in
high school when she lost her
mother to cancer. A short time
later, her father succumbed to
lung cancer. Through her grief,
LoRusso realized her life’s path—
to become a physician and help
improve outcomes for people
with cancer.

“It became a defining moment
in my life,” said LoRusso, who
has more than 25 years of expertise in medical oncology, drug
development, and early-phase
clinical trials. “At the time my
parents died, there weren’t good
therapies, and I was determined
to develop new, better drugs to
treat cancer.”
Today, the Detroit native is
internationally recognized for
bringing promising early-stage
anticancer therapeutics to the
clinic, among them TDM-1, now
known as ado-trastuzumab
emtansine, or Kadcyla®. As a
clinical investigator assisting
Genentech in developing Kadcyla,
she studied “such questions as

EDDIE TORRES PHOTO

Patricia LoRusso, Yale
Cancer Center’s new
associate director of
innovative medicine,
sees her role as a mix
of clinical research and
translational medicine.
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How the Grinch Stole the
Yale System!
Moms in need can get
help in the supermarket
Auction raises $26,890
to address hunger and
homelessness
Full stories and event
photo galleries, as well
as other online-only
content, can be found
on our home page at
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whether the drug impacts on conduction mechanisms of the heart,
how it is dosed in patients with
liver dysfunction, how it interacts
with other agents in terms of toxicity and potential efficacy.”
Clinical trials, she said, have
evolved in such a way that there
is less distinction between Phase
I and II trials. This means more
targeted, tumor-specific therapies are being studied and at earlier stages. LoRusso and other
researchers are seeking patients
with specific tumor types as they
“carry out clinical trials to answer
pivotal clinical questions in
anticipation of FDA submission
and eventual approval of drugs.”
Most of the patients LoRusso
and her team care for have
recurrent cancers that have
defied conventional treatments.
“It’s a huge motivator when
you can help [extend the life of] a
patient who would otherwise be
dying of advanced cancer,” she
said. Even more motivating are
those occasions when she cannot
help them at all. “You realize how
much harder you have to work.”
But she sees the future as
bright, thanks in large part to
a greater understanding of the
biology and genomics of the disease. “This is undoubtedly the
most exciting time to be developing new cancer drugs, and
we are making progress,” said
LoRusso. “My mother would
have had a much better prognosis and may actually have been
cured of her disease had she
been diagnosed in 2014 instead
of 1970.”

LoRusso, who earned her
doctorate in osteopathic medicine at Michigan State University
in 1981, lives in Hamden with her
husband, Julian. They have three
(now adult) adopted children.
“They are my best friends, and we
have a lot of fun together.”
—Amanda Crowe

»

How an 18th-century
doctor enticed a
librarian to study the
history of medicine

Melissa J. Grafe, Ph.D., likes to
reach back in time to tell the
story of John Archer, the first
graduate of an American medical school program. Practicing in
18th-century Pennsylvania, and
confronted with a child whose
symptoms resembled what we
now call diphtheria, Archer
discovered a treatment using a
native American plant. A dose
of Seneca snakeroot, a powerful
emetic, allowed the suffocating
child to breathe again.
Use of the treatment began to
spread after Archer told his five
physician sons and 35 apprentices
about his successful experimentation with Seneca snakeroot.
“I started to delve into the
story of this man, and his sons,
and his apprentices,” Grafe, the
John R. Bumstead Librarian
for Medical History, said of the
physician who was the subject
of her dissertation at Johns
Hopkins University. In 1768
Archer became the first graduate of the School of Medicine of

the College of Philadelphia, now
the University of Pennsylvania.
“His story is why I became interested in medical education and
apprenticeship. People learn
medicine in so many different
ways. How does it play out in a
family whose members are all so
interested in medicine?”
Her interest in the history
of medicine had begun earlier,
during her undergraduate days
at Ursinus College in her native
Pennsylvania, when she read
the Pulitzer Prize-winning
A Midwife's Tale, by Laurel
Thatcher Ulrich.
Now, Grafe pursues her interests in medical education and the
history of medicine at work every
day. As director of the Medical
Historical Library, she helps
students and scholars navigate
its collections, housed within
the Cushing/Whitney Medical
Library. She curates exhibits
that showcase materials from
the library’s more than 140,000
volumes, as well as thousands of
manuscripts, drawings, prints,
incunabula, and other items
spanning every era of medical
history. Recent exhibits range
from the 16th-century anatomical drawings of Vesalius, some of
which incorporate an ingenious
lift-the-flap design not unlike
what we see in children’s books
today, to 1970s-era Technicolor
posters highlighting the dangers
of excessive drinking.
After college, Grafe worked
at historical sites in Pennsylvania
and North Dakota, curating
exhibits, conducting tours, and

JOANNE WILCOX

working on community outreach and education. In North
Dakota, where the distance
to a hospital can be great, she
also trained as an EMT. It was
then, Grafe said, that “I became interested in how people
heal themselves.”
Grafe completed her Ph.D. at
Johns Hopkins in 2009 and then
did postdoctoral work through
the Council on Library and
Information Resources. She was
a librarian at Lehigh University
when the position at the Medical
Historical Library became open.
She jumped at the opportunity.
“This is a once-in-every-20-or30-year position,” she said.
“This is the kind of collection you
want to be a part of.” Grafe came
to Yale in 2011 and lives in North
Guilford with her husband and
two young sons.
In addition to overseeing
library collections, Grafe works
with medical school faculty.
“They find great materials in
their own departments and want
to do something with them, or
want to know more about the
history of their own fields.” She
and the library staff have been
working with members of the
Department of Surgery, helping them locate materials for an
upcoming book and exhibit on
the department’s history. “By
going back 20, 30, or 40 years,
you can get to understand how
a field has changed,” Grafe said,
“and why it is the way it is now.”
Digitization of the library’s
collections is another important piece of Grafe’s work. “Our

goal is to make our collections
widely available to everybody.
That’s why we digitize; we want
the collections to be used.” The
library also offers alumni the
chance to digitize their own
medical school theses and add
their own work as Yale students
to the online archives.
Though online access is
vital, nothing, Grafe noted, can
replace seeing the collections in
person. “A digital image gives
you a snapshot, but if you actually come to see the physical
piece, you end up understanding more about it; it generates new questions.” And, she
said, there is always the “wow”

factor: the chance to be in the
presence of the past's medical
heroes. The library holds pieces
from many scientific greats:
Newton, Kepler, and Copernicus,
to name a few.
“Can you imagine touching a
letter written by Charles Darwin
in 1859?” Grafe asked. It is this
kind of irreplaceable experience
a library can provide, one that
can inspire a scientist to experiment anew.
—Jeanna Canapari

Melissa Grafe’s doctoral
dissertation on an 18thcentury Pennsylvania
doctor sparked her
fascination with the history of medical education and apprenticeship.
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question and answer

		 Who is Nicole McNeer
and how does she
		 win so many awards?
OV E R T H E PA S T T WO D E C A D E S

only a handful of M.D./

Ph.D. students have completed the program in six years
Nicole McNeer, a recent
graduate of the M.D./Ph.D.
Program, was included
in Forbes magazine’s 2015
list of 30 under 30 in
Science & Healthcare,
which recognizes rising
stars in the field.

(the average is seven or eight). Among them is Nicole
McNeer, M.D. ’14, Ph.D. ’14, whose career path straddles
pediatrics and biomedical engineering. While she was
fast-tracking through the program, she also earned three
prestigious awards—for the med school graduate who
best exemplifies the qualities of a pediatrician; the most
outstanding dissertation by an M.D./Ph.D. student; and
exceptional achievement in engineering research.
“As far back as I can remember,”
says McNeer, “I thought that
research and science were the
coolest things in the world.” Her
parents, chemists who came
from Bangladesh and now work
at Kodak and 3M in Minnesota,
encouraged her with chemistry
and electronics kits.
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In January, McNeer garnered
yet another honor. Forbes magazine included the 27 year old
in its 2015 list of 30 under 30 in
Science & Healthcare, which
recognizes young people with
a record of achievement and
promise. Soon after, McNeer
spoke with Yale Medicine.

Q&A WITH

Nicole
McNeer
as the correct one. Most of

Bible. I think the audience

my thesis focused on deliv-

was confused about when

ery of these small molecules

we were married because

using nanoparticles. The

there were 10 different

second part of my thesis was

times when they said “you

When did you become
interested in biomedical
engineering? I had always

about applying this tech-

internship. Dancing, dressing

are married” in multiple

nology to editing the gene

up, and seeing friends have

languages.

responsible for cystic fibro-

all gone by the wayside.

been a math and physics

sis. It’s caused by a single

nerd. When I was think-

gene defect, so it was a very

ing about doing an M.D./

amenable target for this

Ph.D. program, getting

type of technology.

the clinical and research

How are you juggling
your internship and
research? For the past few

who was in Forbes’ 30

months my research has

nated me, and Forbes asked

been mostly writing and

for information about me,

paper revisions—stuff I can

from me and other people.

and physics background.

something that had to do

do wherever I am. I’ll have

I am not sure who all the

Biomedical engineering

with hematology, and I had

my computer with me, and

other people were. It was a

done some rotations in adult

when I have a moment I’ll

little bit embarrassing. This

hematology and oncology,

work on writing, or editing,

type of subjective award is

What was the subject of
your thesis? My research is

which was interesting.

or data analysis. There are

about 5 percent what you

I really enjoyed my rotations

a number of people who are

do and 95 percent luck and

focused on site-specific gene

in pediatric hematology

continuing various aspects

who you know and hav-

editing. That’s like taking

and oncology. I liked work-

of the projects I’d been

ing someone nominate you.

a little piece of whiteout

ing with families and I liked

working on. It has been

Within Yale there are a lot

to the instruction manual,

how pediatric oncology

really cool to see the proj-

of people who are equally

getting rid of the one- or

is set up from a research

ects branch out in different

qualified, but it was an

two-letter typo that you

standpoint.

directions.

honor to be lucky enough to

How did you meet your
husband, James McNeer?

What are your career goals?

It was my freshman year

My ideal job would be as a

thetic small molecules that

You’re also known around
campus as a member
of the Yale Belly Dance
Society. My sister, who

at Harvard, and he was a

pediatric physician/scientist

are similar to DNA. Instead

went to Harvard with me,

sophomore. He was look-

at an academic institution;
to have my own lab; and

have, and replacing it with
the correct letters. There
are several ways of doing
this. I have been using syn-
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under 30 last year nomi-

How did you choose pediatrics? I knew I would do

seemed like a good fit.

John Curtis

How did you get nominated
for 30 under 30? A friend

try and use my math

experience, I wanted to

CONDUCTED BY

be picked for this prize.

of the regular sugar type

convinced me to take an

ing on Facebook for a girl

of backbone that DNA has,

introductory course. I’d never

who was interested in video

also my own clinical prac-

they have a protein type

done any other type of dance,

games. We played StarCraft

tice, most likely in pediatric

of backbone that binds

but I found the class really

against each other; then we

hematology and oncology.

to the DNA in the cell. It

fun. When I came to Yale, I

started dating. Since college

makes it look like there’s a

tried out for the Yale Belly

he’s been working at a small

lesion in the cell, which the

Dance Society, practiced

hedge fund.

cell wants to fix. The cell

very hard, and got in. I have

brings in its own correc-

taken a break from the group

ago. We had his pastor from

tion machinery, and if you

because of the demands of

Massachusetts and one of

We got married five years

include a template with the

my uncles, who was train-

sequence that you want, in

ing as an imam, preside over

some cases you’re lucky and

the wedding, with readings

the cell uses your sequence

from the Koran and the

watch a short film about
Nicole McNeer at
youtube.com/YaleMedicine

{ To nominate a subject for Q&A, contact

Yale Medicine, 1 Church Street, Suite 300, New Haven, CT 06510 or email ymm@yale.edu
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book review
“I realized that the quality of
MS care could be improved
by providing objective infor-

		 Yale M.D./Ph.D. takes unconventional
path to develop a new paradigm of care
By Cathy Shufro

efficacy of these lifestyle and
unconventional approaches

Under “walking prob-

to people with MS and also to

lems,” Bowling mentions

health professionals.

the standard medications

“My patients were

and then lists 10 other “pos-

immersed in these therapies

sibly effective lifestyle and

that clearly were important

unconventional therapies,”

to them—whether there was

including cooling, tai chi, and

evidence that they worked

therapeutic horseback rid-

or not.” Even physicians and

ing. Much of the book is given

When he returned to his

Francisco, and spent three

scientists who were patients

over to Bowling’s elaboration

native Colorado 20 years ago

years as a fellow at Harvard.

used unconventional thera-

on 49 approaches from acu-

to treat people with multiple

pies and were interested in

puncture to yoga. For each,

sclerosis, Allen C. Bowling,

I have such a great toolbox

lifestyle approaches, said

Bowling discusses effective-

M.D. ’88, Ph.D. ’88, believed

for doing clinical practice at

Bowling, who runs an MS

ness, possible interactions

he was well prepared. After

a high level.’ ” Before long,

practice affiliated with

with standard care, hazards,

earning a medical degree and

however, Bowling recog-

the Colorado Neurological

and side effects. He cites stud-

a doctorate in pharmacol-

nized gaps in his knowledge.

Institute and is a clinical

ies and recommends further

professor of neurology at the

reading. Lifestyle, alternative,

University of Colorado.

and conventional medicine

ogy at Yale, he completed his

“I was thinking, ‘Wow!

“There’s so much I don’t know,

neurology residency at the

so much I didn’t get, in more

University of California, San

than a decade of training.”
This realization grew out

Bowling set out to evaluate

seven-step approach that may

of the nature of multiple

style strategies. His approach

be easily followed by patients

sclerosis (MS): this disease of

is to critically review articles

and professionals.

the central nervous system

on a topic related to lifestyle

is incurable and unpredict-

or alternative medicine and

to explore things and extract

able and causes a constella-

distill them into a form that’s

what’s helpful to them,” said

user-friendly for clinicians

Bowling. He has tried much

his patients generally took

and people with MS, he said.

of what his patients pur-

The result is Optimal

sue, both to understand his

MS, Bowling discovered that

Health with Multiple Sclerosis:

patients’ experiences and

most were interested in how

A Guide to Integrating Life-

for his own well-being.
For instance, he now eats

such lifestyle issues as diet

style, Alternative, and

and exercise affect the disease.

Conventional Medicine.

a vegetarian diet on week-

More than half pursued strat-

For each of the main manifes-

days and has worked to

egies not dreamed of in the

tations of MS, the book briefly

understand his psychologi-

medical school curriculum:

describes potential therapies

cal makeup, aided by “a few

reflexology, removal of dental

and lifestyle modifications.

decades of free psycho-

fillings, marijuana, magnets,

therapy at home” thanks to

pressurized oxygen, and

his psychologist-wife, Diana

prayer. However, at that

S. Bowling, Ph.D.

time, there were not any reli-

Bowling provides information
about lifestyle and unconventional therapies on his website,
neurologycare.net/CAM

able sources of MS-specific
information in these areas.

Yale Medicine, 1 Church Street, Suite 300, New Haven, CT 06510 or email ymm@yale.edu
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“I encourage my patients

tion of symptoms. Although
conventional medications for

{ Send notices of new books to

strategies are integrated into a

these unconventional and life-

T H I S PA G E , P H O T O P R O V I D E D B Y P U B L I S H E R ; O P P O S I T E PA G E , J O H N C U R T I S P H O T O

Lifestyle strategies
and alternative medicine

mation about the safety and

end note

All welcome Dumbledore!!!
“P R O F E S S O R D U M B L E D O R E ”

(aka Richard Belitsky, M.D., HS ’82, FW ’83, deputy

dean for education) came to the School of Medicine in January to introduce a
traveling exhibit created by the National Library of Medicine (NLM). “Harry
Potter’s World: Renaissance Science, Magic, and Medicine” uses the seven books
about the boy magician as a launching pad for an exploration of science. The magic
in the books is based in part, says the NLM, on Renaissance traditions—alchemy,
astrology, and natural philosophy—that had a role in developing Western science.
Middle and elementary school students enjoyed a scavenger hunt, which had
them scouring the library for the initials of someone wearing a wizard’s hat,
a paw print from Finn the Therapy Dog, stickers in the library’s brain room, and
other items. Jun Wan, a visiting research scientist, donned Harry Potter glasses
for a photo with “Professor Dumbledore.”
“If I can conjure up just a little bit of magic and wizardry,” said Belitsky, the
Harold W. Jockers Associate Professor of Medical Education, “I’m going to
try to make myself disappear and hope that all of you forever forget this moment.”
—John Curtis

